Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay.

allergy cell-cell interaction cell-in-cell structures innate immune response intravital imaging leukocyte dynamics mast cell neutrophil

Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 31 07 2023
revised: 10 04 2024
accepted: 08 07 2024
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

Neutrophils are sentinel immune cells with essential roles for antimicrobial defense. Most of our knowledge on neutrophil tissue navigation derived from wounding and infection models, whereas allergic conditions remained largely neglected. Here, we analyzed allergen-challenged mouse tissues and discovered that degranulating mast cells (MCs) trap living neutrophils inside them. MCs release the attractant leukotriene B4 to re-route neutrophils toward them, thus exploiting a chemotactic system that neutrophils normally use for intercellular communication. After MC intracellular trap (MIT) formation, neutrophils die, but their undigested material remains inside MC vacuoles over days. MCs benefit from MIT formation, increasing their functional and metabolic fitness. Additionally, they are more pro-inflammatory and can exocytose active neutrophilic compounds with a time delay (nexocytosis), eliciting a type 1 interferon response in surrounding macrophages. Together, our study highlights neutrophil trapping and nexocytosis as MC-mediated processes, which may relay neutrophilic features over the course of chronic allergic inflammation.

Identifiants

pubmed: 39096902
pii: S0092-8674(24)00774-8
doi: 10.1016/j.cell.2024.07.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Michael Mihlan (M)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster 48149, Germany. Electronic address: michael.mihlan@uni-muenster.de.

Stefanie Wissmann (S)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Institute for Biomechanics, ETH Zürich, Zürich 8092, Switzerland.

Alina Gavrilov (A)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Roche Pharma Research and Early Development (pRED), Cardiovascular, Metabolism, Immunology, Infectious Diseases and Ophthalmology (CMI2O), Roche Innovation Center, Basel 4070, Switzerland.

Lukas Kaltenbach (L)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany.

Marie Britz (M)

Department of Dermatology, Universitätsklinikum Münster, Münster 48149, Germany.

Kristin Franke (K)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin 12203, Germany; Charité-Universitätsmedizin Berlin, Institute of Allergology, Berlin 12203, Germany.

Barbara Hummel (B)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany.

Andrea Imle (A)

Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg 69117, Germany.

Ryo Suzuki (R)

Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.

Manuel Stecher (M)

Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster 48149, Germany.

Katharina M Glaser (KM)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Institut Curie, PSL Research University, INSERM U932, Paris 75005, France.

Axel Lorentz (A)

Institute of Nutritional Medicine, University of Hohenheim, Stuttgart 70593, Germany.

Peter Carmeliet (P)

Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven 3000, Belgium; Center for Biotechnology, Khalifa University of Science and Technology, PO Box 127788, Abu Dhabi, United Arab Emirates.

Takehiko Yokomizo (T)

Department of Biochemistry, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Ingo Hilgendorf (I)

Department of Cardiology and Angiology, University Heart Center and Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.

Ritwick Sawarkar (R)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Medical Research Council (MRC) Toxicology Unit and Department of Genetics, University of Cambridge, Cambridge CB21QR, UK.

Alba Diz-Muñoz (A)

Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg 69117, Germany.

Joerg M Buescher (JM)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany.

Gerhard Mittler (G)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany.

Marcus Maurer (M)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin 12203, Germany; Charité-Universitätsmedizin Berlin, Institute of Allergology, Berlin 12203, Germany.

Karoline Krause (K)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin 12203, Germany; Charité-Universitätsmedizin Berlin, Institute of Allergology, Berlin 12203, Germany.

Magda Babina (M)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin 12203, Germany; Charité-Universitätsmedizin Berlin, Institute of Allergology, Berlin 12203, Germany.

Luise Erpenbeck (L)

Department of Dermatology, Universitätsklinikum Münster, Münster 48149, Germany.

Marcus Frank (M)

Medical Biology and Electron Microscopy Center, Rostock University Medical Center, Rostock 18057, Germany; Department Life, Light and Matter, Rostock University, Rostock 18051, Germany.

Angelika S Rambold (AS)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany.

Tim Lämmermann (T)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg 79108, Germany; Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster 48149, Germany. Electronic address: laemmermann@uni-muenster.de.

Classifications MeSH